cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Spero Therapeutics Inc
10 own
15 watching
Current Price
$1.59
$0.02
(1.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
59.41M
52-Week High
52-Week High
1.94000
52-Week Low
52-Week Low
0.99000
Average Volume
Average Volume
0.18M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization59.41M
icon52-Week High1.94000
icon52-Week Low0.99000
iconAverage Volume0.18M
iconDividend Yield--
iconP/E Ratio--
What does the Spero Therapeutics Inc do?
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company s product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Spero Therapeutics Inc make?
News & Events about Spero Therapeutics Inc.
Globe Newswire
1 year ago
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas, involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., March 06, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas, involving rare diseases and multi-drug resistant (MDR) ...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR...
Frequently Asked Questions
Frequently Asked Questions
What is Spero Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Spero Therapeutics Inc shares?
plus_minus_icon
How can I buy Spero Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Spero Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Spero Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Spero Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Spero Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Spero Therapeutics Inc?
plus_minus_icon
What percentage is Spero Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Spero Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.59
$0.02
(1.27%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00